Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eric Lloyd
The Urate-Lowering Efficacy and Safety of Febuxostat in the Treatment of the Hyperuricemia of Gout: The CONFIRMS Trial
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Related publications
Febuxostat: The Evidence for Its Use in the Treatment of Hyperuricemia and Gout
Core Evidence
Medicine
Reviews
References
Pharmacology
Urate Transporters: Transforming the Face of Hyperuricemia and Gout
Journal of Rheumatology
Rheumatology
Allergy
Immunology
The Future of Febuxostat After the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities (CARES) Trial: Who CARES?
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
Pleiotropic Effect of the ABCG2 Gene in Gout: Involvement in Serum Urate Levels and Progression From Hyperuricemia to Gout
Arthritis Research & Therapy
Intermittent Control of Hyperuricemia in the Treatment of Gout: 186
Pediatric Research
Child Health
Pediatrics
Perinatology
Adequacy of Online Patient Information Resources on Gout and Potentially Curative Urate-Lowering Treatment
Arthritis Care and Research
Rheumatology
Gout, Urate-Lowering Therapy, and Uric Acid Levels Among Adults in the United States
Arthritis Care and Research
Rheumatology
Autoinflammation in the Pathogenesis of Gout and Hyperuricemia
Clinical pharmacology and therapy
Erratum To: Comparative Effectiveness of Urate Lowering With Febuxostat Versus Allopurinol in Gout: Analyses From Large U.S. Managed Care Cohort
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
